These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12871443)
1. Thalidomide and thrombosis in multiple myeloma. Barbui T; Falanga A J Thromb Haemost; 2003 Mar; 1(3):421-2. PubMed ID: 12871443 [No Abstract] [Full Text] [Related]
2. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma. Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478 [TBL] [Abstract][Full Text] [Related]
3. Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making. Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G Thromb Haemost; 2004 Apr; 91(4):834-6. PubMed ID: 15045155 [No Abstract] [Full Text] [Related]
4. Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis. Rus C; Bazzan M; Palumbo A; Bringhen S; Boccadoro M J Thromb Haemost; 2004 Nov; 2(11):2063-5. PubMed ID: 15550053 [No Abstract] [Full Text] [Related]
5. Arterial thrombosis in four patients treated with thalidomide. Scarpace SL; Hahn T; Roy H; Brown K; Paplham P; Chanan-Khan A; van Besien K; McCarthy PL Leuk Lymphoma; 2005 Feb; 46(2):239-42. PubMed ID: 15621807 [TBL] [Abstract][Full Text] [Related]